Binding of mazindol and analogs to the human serotonin and dopamine transporterss

Molecular Pharmacology

Volumn 85, Issue 2, 2014, Pages 208-217

  Severinsen, Kasper ^a   Koldsø, Heidi ^b   Thorup, Katrine Almind Vinberg ^a   Schjøth Eskesen, Christina ^b   Møller, Pernille Thornild ^a   Wiborg, Ove ^a   Jensen, Henrik Helligsø ^b   Sinning, Steffen ^a   Schiøtt, Birgit ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; DRUG ANALOG; HORMONE BINDING PROTEIN; MAZINDOL; PHENYLALANINE; SEROTONIN TRANSPORTER; TYROSINE;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; COCAINE DEPENDENCE; DRUG BINDING SITE; DRUG DESIGN; DRUG INHIBITION; ENANTIOMER; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; PRIORITY JOURNAL;

EID: 84891849527     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.088922     Document Type: Article

References (53)

1. Acri JB (2008) In vivo studies of dopamine transporter function, in Dopamine Transporters: Chemistry, Biology, and Pharmacology (Trudell ML, Izenwasser S, and Wang B, eds) pp 391-437
2. Wiley, Hoboken, NJ. Andersen J, Taboureau O, Hansen KB, Olsen L, Egebjerg J, Strømgaard K, and Kristensen AS (2009) Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants. J Biol Chem 284:10276-10284
3. Angel I, Taranger MA, Claustre Y, Scatton B, and Langer SZ (1988) Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro. Life Sci 43:651-658
4. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, and Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem 273:19459-19468
5. Bas DC, Rogers DM, and Jensen JH (2008) Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins 73:765-783
6. Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648-5652
7. Berger P, Gawin F, and Kosten TR (1989) Treatment of cocaine abuse with mazindol. Lancet 1:283.PubMed
8. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, Raniszewska K, Newman AH, Javitch JA, Weinstein H, and Gether U et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11: 780-789
9. Beuming T, Shi L, Javitch JA, and Weinstein H (2006) A comprehensive structurebased alignment of prokaryotic and eukaryotic neurotransmitter/Na1 symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol 70:1630-1642
10. Celik L, Schiøtt B, and Tajkhorshid E (2008a) Substrate binding and formation of an occluded state in the leucine transporter. Biophys J 94:1600-1612
11. Celik L, Sinning S, Severinsen K, Hansen CG, Møller MS, Bols M, Wiborg O, and Schiøtt B (2008b) Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation. J Am Chem Soc 130:3853-3865
12. Chait LD, Uhlenhuth EH, and Johanson CE (1987) Reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242: 777-783
13. Chen N and Reith MEA (2002) Structure-function relationship for biogenic amine neurotransmitter transporters, in Neurotransmitter Transporters: Structure, Function, and Regulation (Reith MEA, ed) pp 53-109
14. Humana Press, Totowa, NJ. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, and Nottoli T et al. (2006) Abolished cocaine reward in mice with a cocaineinsensitive dopamine transporter. Proc Natl Acad Sci USA 103:9333-9338
15. Cho AE, Guallar V, Berne BJ, and Friesner R (2005) Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach. J Comput Chem 26:915-931
16. Dutta AK, Zhang S, Kolhatkar R, and Reith MEA (2003) Dopamine transporter as target for drug development of cocaine dependence medications. Eur J Pharmacol 479:93-106
17. Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, and Janowsky A (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J Pharmacol Exp Ther 289:877-885
18. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M, Pieper U, and Sali A (2007) Comparative protein structure modeling using MODELLER. Curr Protocol Prot Sci 2:2.9
19. Fiser A, Feig M, Brooks CL, 3rd, and Sali A (2002) Evolution and physics in comparative protein structure modeling. Acc Chem Res 35:413-421
20. Forrest LR, Tavoulari S, Zhang YW, Rudnick G, and Honig B (2007) Identification of a chloride ion binding site in Na1/Cl -dependent transporters. Proc Natl Acad Sci USA 104:12761-12766
21. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, and Perry JK et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1 Method and assessment of docking accuracy. J Med Chem 47:1739-1749
22. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, and Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177-6196
23. Gabrielsen M, Kurczab R, Ravna AW, Kufareva I, Abagyan R, Chilmonczyk Z, Bojarski AJ, and Sylte I (2012) Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol. Eur J Med Chem 47:24-37
24. Halgren TA (1999) MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecularinteraction energies and geometries. J Comput Chem 20:730-748
25. Halgren TA (1996) Merck Molecular Force Field: I. Basis, form, scope, parameterization and performance of MMFF94 J Comput Chem 17:490-519
26. Hehre WJ, Ditchfield R, and Pople JA (1972) Self-consistent molecular orbital methods. XII. Future extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules. J Chem Phys 56:2257-2261
27. Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, and Blakely RD (2006) Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J Biol Chem 281:2012-2023
28. Houlihan WJ and Parrino VA (1982) Directed lithiation of 2-phenyl- and 2-(o-methylphenyl) imidazoline. J Org Chem 47:5177-5180
29. Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, and Kopajtic TA (2002) Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter. J Med Chem 45:4097-4109
30. Javitch JA, Blaustein RO, and Snyder SH (1984) [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 26:35-44
31. Jørgensen AM, Tagmose L, Jørgensen AMM, Topiol S, Sabio M, Gundertofte K, Bøgesø KP, and Peters GH (2007) Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site. ChemMedChem 2:815-826
32. Jorgensen WL and Tirado-Rives J (1988) The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110:1657-1666
33. Kharkar PS, Dutta AK, and Reith MEA (2008) Structure-activity relationship study of piperidine derivates for dopamine transporters, in Dopamine Transporters: Chemistry, Biology, and Pharmacology (Trudell ML, Izenwasser S, and Wang B, eds) pp 233-264
34. Wiley, Hoboken, NJ. Koldsø H, Autzen HE, Grouleff J, and Schiøtt B (2013a) Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations. PLoS ONE 8:e63635
35. Koldsø H, Christiansen AB, Sinning S, and Schiøtt B (2013b) Comparative modeling of the human monoamine transporters: similarities in substrate binding. ACS Chem Neurosci 4:295-309
36. Koldsø H, Noer P, Grouleff J, Autzen HE, Sinning S, and Schiøtt B (2011) Unbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(1) ion release. PLOS Comput Biol 7:e1002246
37. Koldsø H, Severinsen K, Tran TT, Celik L, Jensen HH, Wiborg O, Schiøtt B, and Sinning S (2010) The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations. J Am Chem Soc 132:1311-1322
38. Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302
39. Laskowski RA, MacArthur MW, Moss DS, and Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26:283-291
40. Lee C, Yang W, and Parr RG (1988) Development of the Colle-Salvetti correlationenergy formula into a functional of the electron density. Phys Rev B Condens Matter 37:785-789
41. Lee SH, Chang MY, Lee KH, Park BS, Lee YS, Chin HR, and Lee YS (2000) Importance of valine at position 152 for the substrate transport and 2betacarbomethoxy- 3beta-(4-fluorophenyl)tropane binding of dopamine transporter. Mol Pharmacol 57:883-889
42. Li H, Robertson AD, and Jensen JH (2005) Very fast empirical prediction and rationalization of protein pKa values. Proteins 61:704-721
43. Murphy RB, Philipp DM, and Freisner RA (2000) A mixed quantum mechanics/ molecular mechanics (QM/MM) method for large-scale modeling of chemistry in protein environments. J Comput Chem 21:1442-1457
44. Penmatsa A, Wang KH, and Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503:85-90
45. Severinsen K, Kraft JF, Koldsø H, Vinberg KA, Rothman RB, Partilla JS, Wiborg O, Blough B, Schiøtt B, and Sinning S (2012) Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters. ACS Chem Neurosci 3: 693-705
46. Sherman W, Day T, Jacobson MP, Friesner RA, and Farid R (2006) Novel procedure for modeling ligand/receptor induced fit effects. J Med Chem 49:534-553
47. Sinning S, Musgaard M, Jensen M, Severinsen K, Celik L, Koldsø H, Meyer T, Bols M, Jensen HH, and Schiøtt B et al. (2010) Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. J Biol Chem 285:8363-8374
48. Stephens PJ, Devlin FJ, Chabalowski CF, and Frisch MJ (1994) Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J Phys Chem 98:11623-11627
49. Stine SM, Krystal JH, Kosten TR, and Charney DS (1995) Mazindol treatment for cocaine dependence. Drug Alcohol Depend 39:245-252
50. Thomsen M, Han DD, Gu HH, and Caine SB (2009) Lack of cocaine selfadministration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331:204-211
51. Thomsen R and Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49:3315-3321
52. Yamashita A, Singh SK, Kawate T, Jin Y, and Gouaux E (2005) Crystal structure of a bacterial homologue of Na1/Cl-dependent neurotransmitter transporters. Nature 437:215-223
53. Zomot E, Bendahan A, Quick M, Zhao Y, Javitch JA, and Kanner BI (2007) Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature 449:726-730.